Form 4: 89bio CEO Rohan Palekar Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Rohan Palekar, CEO of 89bio, Inc., sold 4,477 shares of common stock at $10.76 per share on February 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 26, 2024, Rohan Palekar, the CEO of 89bio, Inc. (ETNB), sold 4,477 shares of the company's common stock.
- The sale was executed at a price of $10.76 per share.
- This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan that was adopted on July 5, 2023.
- Following the transaction, Palekar directly owns 486,889 shares of 89bio, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a negative outlook on the company.
Industry Context
Insider sales are common and can be for various reasons, including diversification or personal financial planning. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on current inside information.
Stakeholder Impact
- The sale could have a minor negative impact on shareholder sentiment, although the pre-planned nature of the sale mitigates this.
Key Dates
| Date | Description |
|---|---|
| July 5, 2023 | Date the Rule 10b5-1 trading plan was adopted. |
| February 26, 2024 | Date of the stock sale transaction. |
| February 28, 2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.